1. Coderre J., Glass, J., Fairchild, R., Roy, U., Cohen, S. & Faud, I. (1987) Selective Targeting of BPA to Melanoma for Neutron Capture Therapy, Cancer Res. 47 6377–6383.
2. Wheeler, F., Griebenow, M., Wessol, D., Nigg, D. & Anderl, R. (1989) A stoichastic model for high LET response for BNCT, in Basic Life Sciences: Clinical Aspects of Neutron Capture Therapy, eds. Fairchild, R., Bond, V. & Woodhead, A. (Plenum Press, New York), pp 165–178.
3. Brewster, M., Simplins, J., Hora, M., Stern, W. & Bodor, N. (1989) The Potential Use of Cyclodextrins in Parenteral Formulations, J. Parent. Sci. Technol.
43 231–240.
4. Yoshino, K., Suzuki, A., Mori, Y., Kakihana, H., Honda, C., Mishima, Y., Kobayashi, T. & Kanda, K. (1989) Improvement of Solubility of p-Boronophenylalanine by Complex Formation with Monosaccharides, Strahlenter. Onkol.
165 127–129.
5. LaHann, T., Sills, C., Hematillake, G., Dymock, T. & Daniell, G. (in press) Cardiovascular toxicities associated with i.v. administration of p-BPA formulations, in Proceedings of the Fifth International Symposium on Neutron Capture Therapy, eds. Barth, R. & Soloway A. (Plenum Press, New York).